chr18-10691359-G-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001378183.1(PIEZO2):​c.7215C>T​(p.Ala2405Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.324 in 1,610,936 control chromosomes in the GnomAD database, including 88,549 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 6284 hom., cov: 31)
Exomes 𝑓: 0.33 ( 82265 hom. )

Consequence

PIEZO2
NM_001378183.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.584

Publications

17 publications found
Variant links:
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
  • Gordon syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • arthrogryposis, distal, with impaired proprioception and touch
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
  • arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • connective tissue disorder
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Marden-Walker syndrome
    Inheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 18-10691359-G-A is Benign according to our data. Variant chr18-10691359-G-A is described in ClinVar as Benign. ClinVar VariationId is 261526.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.584 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.35 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIEZO2NM_001378183.1 linkc.7215C>T p.Ala2405Ala synonymous_variant Exon 48 of 56 ENST00000674853.1 NP_001365112.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIEZO2ENST00000674853.1 linkc.7215C>T p.Ala2405Ala synonymous_variant Exon 48 of 56 NM_001378183.1 ENSP00000501957.1 A0A2H4UKA7

Frequencies

GnomAD3 genomes
AF:
0.274
AC:
41579
AN:
151860
Hom.:
6282
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.159
Gnomad AMI
AF:
0.329
Gnomad AMR
AF:
0.238
Gnomad ASJ
AF:
0.355
Gnomad EAS
AF:
0.108
Gnomad SAS
AF:
0.237
Gnomad FIN
AF:
0.323
Gnomad MID
AF:
0.271
Gnomad NFE
AF:
0.354
Gnomad OTH
AF:
0.288
GnomAD2 exomes
AF:
0.282
AC:
70105
AN:
248420
AF XY:
0.289
show subpopulations
Gnomad AFR exome
AF:
0.150
Gnomad AMR exome
AF:
0.176
Gnomad ASJ exome
AF:
0.347
Gnomad EAS exome
AF:
0.101
Gnomad FIN exome
AF:
0.324
Gnomad NFE exome
AF:
0.353
Gnomad OTH exome
AF:
0.298
GnomAD4 exome
AF:
0.330
AC:
480888
AN:
1458956
Hom.:
82265
Cov.:
35
AF XY:
0.329
AC XY:
238437
AN XY:
725722
show subpopulations
African (AFR)
AF:
0.151
AC:
5021
AN:
33360
American (AMR)
AF:
0.184
AC:
8186
AN:
44382
Ashkenazi Jewish (ASJ)
AF:
0.346
AC:
9021
AN:
26078
East Asian (EAS)
AF:
0.137
AC:
5427
AN:
39508
South Asian (SAS)
AF:
0.260
AC:
22282
AN:
85700
European-Finnish (FIN)
AF:
0.322
AC:
17171
AN:
53368
Middle Eastern (MID)
AF:
0.278
AC:
1600
AN:
5758
European-Non Finnish (NFE)
AF:
0.354
AC:
393552
AN:
1110524
Other (OTH)
AF:
0.309
AC:
18628
AN:
60278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
15332
30663
45995
61326
76658
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12268
24536
36804
49072
61340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.274
AC:
41589
AN:
151980
Hom.:
6284
Cov.:
31
AF XY:
0.270
AC XY:
20066
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.159
AC:
6587
AN:
41456
American (AMR)
AF:
0.238
AC:
3628
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.355
AC:
1233
AN:
3470
East Asian (EAS)
AF:
0.108
AC:
560
AN:
5166
South Asian (SAS)
AF:
0.238
AC:
1150
AN:
4822
European-Finnish (FIN)
AF:
0.323
AC:
3405
AN:
10532
Middle Eastern (MID)
AF:
0.262
AC:
77
AN:
294
European-Non Finnish (NFE)
AF:
0.354
AC:
24049
AN:
67964
Other (OTH)
AF:
0.285
AC:
601
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1527
3054
4581
6108
7635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.313
Hom.:
6185
Bravo
AF:
0.259
Asia WGS
AF:
0.170
AC:
595
AN:
3478
EpiCase
AF:
0.353
EpiControl
AF:
0.343

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 30, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gordon syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Marden-Walker syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis, distal, with impaired proprioception and touch Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
4.0
DANN
Benign
0.80
PhyloP100
0.58
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3748421; hg19: chr18-10691357; COSMIC: COSV53286736; API